BIOCON
Biocon Limited
Pharmaceuticals · ₹65,428 Cr market cap
A leading biotechnology company engaged in the manufacture of innovative pharmaceutical products and research services across multiple therapeutic areas. Biocon specializes in biologics, biosimilars, and small molecule drugs, serving patients in oncology, immunology, and diabetes therapeutics globally. The company operates integrated manufacturing facilities and maintains a strong commitment to developing affordable healthcare solutions for patients in emerging markets worldwide.
4
Tracked investors holding
0
Tracked moves
₹404
Share price
Top investors holding Biocon Limited
Plus 1 more tracked investor holding Biocon Limited. Sign in to see them all.
Sign in to view all holders